Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of bosentan on macro- and microvascular function in patients with type 2 diabetes
2007-000221-22Phase 2Active
- Sponsor
- John Pernow
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bosentan in type 2 diabetes mellitus (T2DM), diabetic microangiopathy and albuminuria, sponsored by John Pernow. Primary endpoint: Microvascular endothelial function at 4 weeks. Started Jul 2007; status: active.
02
Drugs
bosentan
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic microangiopathyalbuminuria
Beyond the preview
Go deeper on 2007-000221-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000221-22.